Positron Emission Tomography (PET)-Computed Tomography (CT) in Inflammatory Bowel Disease (IBD)

This study has been terminated.
(No Accrual)
Information provided by (Responsible Party):
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
First received: September 13, 2005
Last updated: October 1, 2015
Last verified: September 2008
The main hypothesis is that PET-CT will be a valuable diagnostic tool in diagnosing and evaluating treatment for IBD.

Condition Intervention Phase
Inflammatory Bowel Diseases
Procedure: PET-CT
Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Pilot Study of the Role of PET-CT for Diagnosis and Assessment of Therapeutic Efficacy in Inflammatory Bowel Disease

Further study details as provided by University of Wisconsin, Madison:

Primary Outcome Measures:
  • Does this technique provide an accurate assessment of disease inflammation compared to standard clinical markers?

Secondary Outcome Measures:
  • Does this technique provide additional information for practitioners on extent of disease?

Study Start Date: October 2004
Study Completion Date: August 2008
Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patient with either Crohn's disease or ulcerative colitis whose disease is flaring

Exclusion Criteria:

  • Indeterminate diagnosis, pregnant, breastfeeding, or other contraindication to PET-CT
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00205062

United States, Wisconsin
University of Wisconsin
Madison, Wisconsin, United States, 53792
Sponsors and Collaborators
University of Wisconsin, Madison
Principal Investigator: Randall Meisner, MD University of Wisconsin, Madison
  More Information

No publications provided

Responsible Party: University of Wisconsin, Madison
ClinicalTrials.gov Identifier: NCT00205062     History of Changes
Other Study ID Numbers: M-2004-0251
Study First Received: September 13, 2005
Last Updated: October 1, 2015
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Inflammatory Bowel Diseases
Intestinal Diseases
Digestive System Diseases
Gastrointestinal Diseases

ClinicalTrials.gov processed this record on November 30, 2015